NEW YORK, Oct. 14, 2019 /PRNewswire/ --
RNA Interference (RNAi) market worldwide is projected to grow by US$39.9 Billion, driven by a compounded growth of 18.5%. Drug Discovery & Development, one of the segments analyzed and sized in this study, displays the potential to grow at over 18.1%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$23.3 Billion by the year 2025, Drug Discovery & Development will bring in healthy gains adding significant momentum to global growth.
Read the full report: https://www.reportlinker.com/p05818086/?utm_source=PRN
- Representing the developed world, the United States will maintain a 17.1% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$1.8 Billion to the region's size and clout in the next 5 to 6 years. Over US$1.5 Billion worth of projected demand in the region will come from Rest of Europe markets. In Japan, Drug Discovery & Development will reach a market size of US$1.2 Billion by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 21.6% over the next couple of years and add approximately US$8.6 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.
- Competitors identified in this market include among others, Alnylam Pharmaceuticals, Inc.; Benitec BioPharma; Ionis Pharmaceuticals, Inc.; Ionis Pharmaceuticals, Inc.; Qiagen, Inc.; Quark Pharmaceuticals, Inc.; Silence Therapeutics PLC
Read the full report: https://www.reportlinker.com/p05818086/?utm_source=PRN
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Global Competitor Market Shares
RNA Interference (RNAi) Competitor Market Share Scenario
Worldwide (in %): 2019 & 2028
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: RNA Interference (RNAi) Global Market Estimates and
Forecasts in US$ Million by Region/Country: 2018-2025
Table 2: RNA Interference (RNAi) Global Retrospective Market
Scenario in US$ Million by Region/Country: 2009-2017
Table 3: RNA Interference (RNAi) Market Share Shift across Key
Geographies Worldwide: 2009 VS 2019 VS 2025
Table 4: Drug Discovery & Development (Application) Global
Opportunity Assessment in US$ Million by Region/Country:
2018-2025
Table 5: Drug Discovery & Development (Application) Historic
Sales Analysis in US$ Million by Region/Country: 2009-2017
Table 6: Drug Discovery & Development (Application) Percentage
Share Breakdown of Global Sales by Region/Country: 2009 VS 2019
VS 2025
Table 7: Therapeutics (Application) Worldwide Sales in US$
Million by Region/Country: 2018-2025
Table 8: Therapeutics (Application) Historic Demand Patterns in
US$ Million by Region/Country: 2009-2017
Table 9: Therapeutics (Application) Market Share Shift across
Key Geographies: 2009 VS 2019 VS 2025
Table 10: Other Applications (Application) Global Market
Estimates & Forecasts in US$ Million by Region/Country:
2018-2025
Table 11: Other Applications (Application) Retrospective Demand
Analysis in US$ Million by Region/Country: 2009-2017
Table 12: Other Applications (Application) Market Share
Breakdown by Region/Country: 2009 VS 2019 VS 2025
Table 13: Oncology (Therapeutics) World Market Estimates and
Forecasts by Region/Country in US$ Million: 2018 to 2025
Table 14: Oncology (Therapeutics) Market Historic Review by
Region/Country in US$ Million: 2009 to 2017
Table 15: Oncology (Therapeutics) Market Share Breakdown by
Region/Country: 2009 VS 2019 VS 2025
Table 16: Ocular Disorders (Therapeutics) World Market by
Region/Country in US$ Million: 2018 to 2025
Table 17: Ocular Disorders (Therapeutics) Historic Market
Analysis by Region/Country in US$ Million: 2009 to 2017
Table 18: Ocular Disorders (Therapeutics) Market Share
Distribution in Percentage by Region/Country: 2009 VS 2019 VS
2025
Table 19: Respiratory Disorders (Therapeutics) World Market
Estimates and Forecasts in US$ Million by Region/Country: 2018
to 2025
Table 20: Respiratory Disorders (Therapeutics) Market Worldwide
Historic Review by Region/Country in US$ Million: 2009 to 2017
Table 21: Respiratory Disorders (Therapeutics) Market
Percentage Share Distribution by Region/Country: 2009 VS 2019
VS 2025
Table 22: Liver Diseases (Therapeutics) Market Opportunity
Analysis Worldwide in US$ Million by Region/Country: 2018 to
2025
Table 23: Liver Diseases (Therapeutics) Global Historic Demand
in US$ Million by Region/Country: 2009 to 2017
Table 24: Liver Diseases (Therapeutics) Market Share
Distribution in Percentage by Region/Country: 2009 VS 2019 VS
2025
Table 25: Neuronal Disorders (Therapeutics) World Market by
Region/Country in US$ Million: 2018 to 2025
Table 26: Neuronal Disorders (Therapeutics) Historic Market
Analysis by Region/Country in US$ Million: 2009 to 2017
Table 27: Neuronal Disorders (Therapeutics) Market Share
Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS
2025
Table 28: Other Therapeutics (Therapeutics) Potential Growth
Markets Worldwide in US$ Million: 2018 to 2025
Table 29: Other Therapeutics (Therapeutics) Historic Market
Perspective by Region/Country in US$ Million: 2009 to 2017
Table 30: Other Therapeutics (Therapeutics) Market Sales
Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
III. MARKET ANALYSIS
GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US RNA Interference (RNAi) Market Share (in %) by Company: 2019
& 2025
Table 31: United States RNA Interference (RNAi) Latent Demand
Forecasts in US$ Million by Application: 2018 to 2025
Table 32: RNA Interference (RNAi) Historic Demand Patterns in
the United States by Application in US$ Million for 2009-2017
Table 33: RNA Interference (RNAi) Market Share Breakdown in the
United States by Application: 2009 VS 2019 VS 2025
Table 34: United States RNA Interference (RNAi) Market
Estimates and Projections in US$ Million by Therapeutics: 2018
to 2025
Table 35: RNA Interference (RNAi) Market in the United States
by Therapeutics: A Historic Review in US$ Million for 2009-2017
Table 36: United States RNA Interference (RNAi) Market Share
Breakdown by Therapeutics: 2009 VS 2019 VS 2025
CANADA
Table 37: Canadian RNA Interference (RNAi) Market Quantitative
Demand Analysis in US$ Million by Application: 2018 to 2025
Table 38: RNA Interference (RNAi) Market in Canada:
Summarization of Historic Demand Patterns in US$ Million by
Application for 2009-2017
Table 39: Canadian RNA Interference (RNAi) Market Share
Analysis by Application: 2009 VS 2019 VS 2025
Table 40: Canadian RNA Interference (RNAi) Market Estimates and
Forecasts in US$ Million by Therapeutics: 2018 to 2025
Table 41: Canadian RNA Interference (RNAi) Historic Market
Review by Therapeutics in US$ Million: 2009-2017
Table 42: RNA Interference (RNAi) Market in Canada: Percentage
Share Breakdown of Sales by Therapeutics for 2009, 2019, and
2025
JAPAN
Table 43: Japanese Demand Estimates and Forecasts for RNA
Interference (RNAi) in US$ Million by Application: 2018 to 2025
Table 44: Japanese RNA Interference (RNAi) Market in US$
Million by Application: 2009-2017
Table 45: RNA Interference (RNAi) Market Share Shift in Japan
by Application: 2009 VS 2019 VS 2025
Table 46: Japanese Market for RNA Interference (RNAi): Annual
Sales Estimates and Projections in US$ Million by Therapeutics
for the Period 2018-2025
Table 47: RNA Interference (RNAi) Market in Japan: Historic
Sales Analysis in US$ Million by Therapeutics for the Period
2009-2017
Table 48: Japanese RNA Interference (RNAi) Market Share
Analysis by Therapeutics: 2009 VS 2019 VS 2025
CHINA
Table 49: Chinese Demand for RNA Interference (RNAi) in US$
Million by Application: 2018 to 2025
Table 50: RNA Interference (RNAi) Market Review in China in US$
Million by Application: 2009-2017
Table 51: Chinese RNA Interference (RNAi) Market Share
Breakdown by Application: 2009 VS 2019 VS 2025
Table 52: Chinese RNA Interference (RNAi) Market Growth
Prospects in US$ Million by Therapeutics for the Period
2018-2025
Table 53: RNA Interference (RNAi) Historic Market Analysis in
China in US$ Million by Therapeutics: 2009-2017
Table 54: Chinese RNA Interference (RNAi) Market by
Therapeutics: Percentage Breakdown of Sales for 2009, 2019, and
2025
EUROPE
Market Facts & Figures
European RNA Interference (RNAi) Market: Competitor Market
Share Scenario (in %) for 2019 & 2025
Table 55: European RNA Interference (RNAi) Market Demand
Scenario in US$ Million by Region/Country: 2018-2025
Table 56: RNA Interference (RNAi) Market in Europe: A Historic
Market Perspective in US$ Million by Region/Country for the
Period 2009-2017
Table 57: European RNA Interference (RNAi) Market Share Shift
by Region/Country: 2009 VS 2019 VS 2025
Table 58: European RNA Interference (RNAi) Addressable Market
Opportunity in US$ Million by Application: 2018-2025
Table 59: RNA Interference (RNAi) Market in Europe:
Summarization of Historic Demand in US$ Million by Application
for the Period 2009-2017
Table 60: European RNA Interference (RNAi) Market Share
Analysis by Application: 2009 VS 2019 VS 2025
Table 61: European RNA Interference (RNAi) Market Estimates and
Forecasts in US$ Million by Therapeutics: 2018-2025
Table 62: RNA Interference (RNAi) Market in Europe in US$
Million by Therapeutics: A Historic Review for the Period
2009-2017
Table 63: European RNA Interference (RNAi) Market Share
Breakdown by Therapeutics: 2009 VS 2019 VS 2025
FRANCE
Table 64: RNA Interference (RNAi) Quantitative Demand Analysis
in France in US$ Million by Application: 2018-2025
Table 65: French RNA Interference (RNAi) Historic Market Review
in US$ Million by Application: 2009-2017
Table 66: French RNA Interference (RNAi) Market Share Analysis:
A 17-Year Perspective by Application for 2009, 2019, and 2025
Table 67: RNA Interference (RNAi) Market in France by
Therapeutics: Estimates and Projections in US$ Million for the
Period 2018-2025
Table 68: French RNA Interference (RNAi) Historic Market
Scenario in US$ Million by Therapeutics: 2009-2017
Table 69: French RNA Interference (RNAi) Market Share Analysis
by Therapeutics: 2009 VS 2019 VS 2025
GERMANY
Table 70: RNA Interference (RNAi) Market in Germany: Annual
Sales Estimates and Forecasts in US$ Million by Application for
the Period 2018-2025
Table 71: German RNA Interference (RNAi) Market in Retrospect
in US$ Million by Application: 2009-2017
Table 72: RNA Interference (RNAi) Market Share Distribution in
Germany by Application: 2009 VS 2019 VS 2025
Table 73: RNA Interference (RNAi) Market in Germany: Recent
Past, Current and Future Analysis in US$ Million by
Therapeutics for the Period 2018-2025
Table 74: German RNA Interference (RNAi) Historic Market
Analysis in US$ Million by Therapeutics: 2009-2017
Table 75: German RNA Interference (RNAi) Market Share Breakdown
by Therapeutics: 2009 VS 2019 VS 2025
ITALY
Table 76: Italian Demand for RNA Interference (RNAi) in US$
Million by Application: 2018 to 2025
Table 77: RNA Interference (RNAi) Market Review in Italy in US$
Million by Application: 2009-2017
Table 78: Italian RNA Interference (RNAi) Market Share
Breakdown by Application: 2009 VS 2019 VS 2025
Table 79: Italian RNA Interference (RNAi) Market Growth
Prospects in US$ Million by Therapeutics for the Period
2018-2025
Table 80: RNA Interference (RNAi) Historic Market Analysis in
Italy in US$ Million by Therapeutics: 2009-2017
Table 81: Italian RNA Interference (RNAi) Market by
Therapeutics: Percentage Breakdown of Sales for 2009, 2019, and
2025
UNITED KINGDOM
Table 82: United Kingdom Demand Estimates and Forecasts for RNA
Interference (RNAi) in US$ Million by Application: 2018 to 2025
Table 83: United Kingdom RNA Interference (RNAi) Market in US$
Million by Application: 2009-2017
Table 84: RNA Interference (RNAi) Market Share Shift in the
United Kingdom by Application: 2009 VS 2019 VS 2025
Table 85: United Kingdom Market for RNA Interference (RNAi):
Annual Sales Estimates and Projections in US$ Million by
Therapeutics for the Period 2018-2025
Table 86: RNA Interference (RNAi) Market in the United Kingdom:
Historic Sales Analysis in US$ Million by Therapeutics for the
Period 2009-2017
Table 87: United Kingdom RNA Interference (RNAi) Market Share
Analysis by Therapeutics: 2009 VS 2019 VS 2025
SPAIN
Table 88: Spanish RNA Interference (RNAi) Market Quantitative
Demand Analysis in US$ Million by Application: 2018 to 2025
Table 89: RNA Interference (RNAi) Market in Spain:
Summarization of Historic Demand Patterns in US$ Million by
Application for 2009-2017
Table 90: Spanish RNA Interference (RNAi) Market Share Analysis
by Application: 2009 VS 2019 VS 2025
Table 91: Spanish RNA Interference (RNAi) Market Estimates and
Forecasts in US$ Million by Therapeutics: 2018 to 2025
Table 92: Spanish RNA Interference (RNAi) Historic Market
Review by Therapeutics in US$ Million: 2009-2017
Table 93: RNA Interference (RNAi) Market in Spain: Percentage
Share Breakdown of Sales by Therapeutics for 2009, 2019, and
2025
RUSSIA
Table 94: Russian RNA Interference (RNAi) Latent Demand
Forecasts in US$ Million by Application: 2018 to 2025
Table 95: RNA Interference (RNAi) Historic Demand Patterns in
Russia by Application in US$ Million for 2009-2017
Table 96: RNA Interference (RNAi) Market Share Breakdown in
Russia by Application: 2009 VS 2019 VS 2025
Table 97: Russian RNA Interference (RNAi) Market Estimates and
Projections in US$ Million by Therapeutics: 2018 to 2025
Table 98: RNA Interference (RNAi) Market in Russia by
Therapeutics: A Historic Review in US$ Million for 2009-2017
Table 99: Russian RNA Interference (RNAi) Market Share
Breakdown by Therapeutics: 2009 VS 2019 VS 2025
REST OF EUROPE
Table 100: Rest of Europe RNA Interference (RNAi) Addressable
Market Opportunity in US$ Million by Application: 2018-2025
Table 101: RNA Interference (RNAi) Market in Rest of Europe:
Summarization of Historic Demand in US$ Million by Application
for the Period 2009-2017
Table 102: Rest of Europe RNA Interference (RNAi) Market Share
Analysis by Application: 2009 VS 2019 VS 2025
Table 103: Rest of Europe RNA Interference (RNAi) Market
Estimates and Forecasts in US$ Million by Therapeutics:
2018-2025
Table 104: RNA Interference (RNAi) Market in Rest of Europe in
US$ Million by Therapeutics: A Historic Review for the Period
2009-2017
Table 105: Rest of Europe RNA Interference (RNAi) Market Share
Breakdown by Therapeutics: 2009 VS 2019 VS 2025
ASIA-PACIFIC
Table 106: Asia-Pacific RNA Interference (RNAi) Market
Estimates and Forecasts in US$ Million by Region/Country:
2018-2025
Table 107: RNA Interference (RNAi) Market in Asia-Pacific:
Historic Market Analysis in US$ Million by Region/Country for
the Period 2009-2017
Table 108: Asia-Pacific RNA Interference (RNAi) Market Share
Analysis by Region/Country: 2009 VS 2019 VS 2025
Table 109: RNA Interference (RNAi) Quantitative Demand Analysis
in Asia-Pacific in US$ Million by Application: 2018-2025
Table 110: Asia-Pacific RNA Interference (RNAi) Historic Market
Review in US$ Million by Application: 2009-2017
Table 111: Asia-Pacific RNA Interference (RNAi) Market Share
Analysis: A 17-Year Perspective by Application for 2009, 2019,
and 2025
Table 112: RNA Interference (RNAi) Market in Asia-Pacific by
Therapeutics: Estimates and Projections in US$ Million for the
Period 2018-2025
Table 113: Asia-Pacific RNA Interference (RNAi) Historic Market
Scenario in US$ Million by Therapeutics: 2009-2017
Table 114: Asia-Pacific RNA Interference (RNAi) Market Share
Analysis by Therapeutics: 2009 VS 2019 VS 2025
AUSTRALIA
Table 115: RNA Interference (RNAi) Market in Australia: Annual
Sales Estimates and Forecasts in US$ Million by Application for
the Period 2018-2025
Table 116: Australian RNA Interference (RNAi) Market in
Retrospect in US$ Million by Application: 2009-2017
Table 117: RNA Interference (RNAi) Market Share Distribution in
Australia by Application: 2009 VS 2019 VS 2025
Table 118: RNA Interference (RNAi) Market in Australia: Recent
Past, Current and Future Analysis in US$ Million by
Therapeutics for the Period 2018-2025
Table 119: Australian RNA Interference (RNAi) Historic Market
Analysis in US$ Million by Therapeutics: 2009-2017
Table 120: Australian RNA Interference (RNAi) Market Share
Breakdown by Therapeutics: 2009 VS 2019 VS 2025
INDIA
Table 121: Indian RNA Interference (RNAi) Market Quantitative
Demand Analysis in US$ Million by Application: 2018 to 2025
Table 122: RNA Interference (RNAi) Market in India:
Summarization of Historic Demand Patterns in US$ Million by
Application for 2009-2017
Table 123: Indian RNA Interference (RNAi) Market Share Analysis
by Application: 2009 VS 2019 VS 2025
Table 124: Indian RNA Interference (RNAi) Market Estimates and
Forecasts in US$ Million by Therapeutics: 2018 to 2025
Table 125: Indian RNA Interference (RNAi) Historic Market
Review by Therapeutics in US$ Million: 2009-2017
Table 126: RNA Interference (RNAi) Market in India: Percentage
Share Breakdown of Sales by Therapeutics for 2009, 2019, and
2025
SOUTH KOREA
Table 127: RNA Interference (RNAi) Market in South Korea:
Recent Past, Current and Future Analysis in US$ Million by
Application for the Period 2018-2025
Table 128: South Korean RNA Interference (RNAi) Historic Market
Analysis in US$ Million by Application: 2009-2017
Table 129: RNA Interference (RNAi) Market Share Distribution in
South Korea by Application: 2009 VS 2019 VS 2025
Table 130: RNA Interference (RNAi) Market in South Korea:
Recent Past, Current and Future Analysis in US$ Million by
Therapeutics for the Period 2018-2025
Table 131: South Korean RNA Interference (RNAi) Historic Market
Analysis in US$ Million by Therapeutics: 2009-2017
Table 132: RNA Interference (RNAi) Market Share Distribution in
South Korea by Therapeutics: 2009 VS 2019 VS 2025
REST OF ASIA-PACIFIC
Table 133: Rest of Asia-Pacific Demand Estimates and Forecasts
for RNA Interference (RNAi) in US$ Million by Application: 2018
to 2025
Table 134: Rest of Asia-Pacific RNA Interference (RNAi) Market
in US$ Million by Application: 2009-2017
Table 135: RNA Interference (RNAi) Market Share Shift in Rest
of Asia-Pacific by Application: 2009 VS 2019 VS 2025
Table 136: Rest of Asia-Pacific Market for RNA Interference
(RNAi): Annual Sales Estimates and Projections in US$ Million
by Therapeutics for the Period 2018-2025
Table 137: RNA Interference (RNAi) Market in Rest of
Asia-Pacific: Historic Sales Analysis in US$ Million by
Therapeutics for the Period 2009-2017
Table 138: Rest of Asia-Pacific RNA Interference (RNAi) Market
Share Analysis by Therapeutics: 2009 VS 2019 VS 2025
LATIN AMERICA
Table 139: Latin American RNA Interference (RNAi) Market Trends
by Region/Country in US$ Million: 2018-2025
Table 140: RNA Interference (RNAi) Market in Latin America in
US$ Million by Region/Country: A Historic Perspective for the
Period 2009-2017
Table 141: Latin American RNA Interference (RNAi) Market
Percentage Breakdown of Sales by Region/Country: 2009, 2019,
and 2025
Table 142: Latin American Demand for RNA Interference (RNAi) in
US$ Million by Application: 2018 to 2025
Table 143: RNA Interference (RNAi) Market Review in Latin
America in US$ Million by Application: 2009-2017
Table 144: Latin American RNA Interference (RNAi) Market Share
Breakdown by Application: 2009 VS 2019 VS 2025
Table 145: Latin American RNA Interference (RNAi) Market Growth
Prospects in US$ Million by Therapeutics for the Period
2018-2025
Table 146: RNA Interference (RNAi) Historic Market Analysis in
Latin America in US$ Million by Therapeutics: 2009-2017
Table 147: Latin American RNA Interference (RNAi) Market by
Therapeutics: Percentage Breakdown of Sales for 2009, 2019, and
2025
ARGENTINA
Table 148: Argentinean RNA Interference (RNAi) Addressable
Market Opportunity in US$ Million by Application: 2018-2025
Table 149: RNA Interference (RNAi) Market in Argentina:
Summarization of Historic Demand in US$ Million by Application
for the Period 2009-2017
Table 150: Argentinean RNA Interference (RNAi) Market Share
Analysis by Application: 2009 VS 2019 VS 2025
Table 151: Argentinean RNA Interference (RNAi) Market Estimates
and Forecasts in US$ Million by Therapeutics: 2018-2025
Table 152: RNA Interference (RNAi) Market in Argentina in US$
Million by Therapeutics: A Historic Review for the Period
2009-2017
Table 153: Argentinean RNA Interference (RNAi) Market Share
Breakdown by Therapeutics: 2009 VS 2019 VS 2025
BRAZIL
Table 154: RNA Interference (RNAi) Quantitative Demand Analysis
in Brazil in US$ Million by Application: 2018-2025
Table 155: Brazilian RNA Interference (RNAi) Historic Market
Review in US$ Million by Application: 2009-2017
Table 156: Brazilian RNA Interference (RNAi) Market Share
Analysis: A 17-Year Perspective by Application for 2009, 2019,
and 2025
Table 157: RNA Interference (RNAi) Market in Brazil by
Therapeutics: Estimates and Projections in US$ Million for the
Period 2018-2025
Table 158: Brazilian RNA Interference (RNAi) Historic Market
Scenario in US$ Million by Therapeutics: 2009-2017
Table 159: Brazilian RNA Interference (RNAi) Market Share
Analysis by Therapeutics: 2009 VS 2019 VS 2025
MEXICO
Table 160: RNA Interference (RNAi) Market in Mexico: Annual
Sales Estimates and Forecasts in US$ Million by Application for
the Period 2018-2025
Table 161: Mexican RNA Interference (RNAi) Market in Retrospect
in US$ Million by Application: 2009-2017
Table 162: RNA Interference (RNAi) Market Share Distribution in
Mexico by Application: 2009 VS 2019 VS 2025
Table 163: RNA Interference (RNAi) Market in Mexico: Recent
Past, Current and Future Analysis in US$ Million by
Therapeutics for the Period 2018-2025
Table 164: Mexican RNA Interference (RNAi) Historic Market
Analysis in US$ Million by Therapeutics: 2009-2017
Table 165: Mexican RNA Interference (RNAi) Market Share
Breakdown by Therapeutics: 2009 VS 2019 VS 2025
REST OF LATIN AMERICA
Table 166: Rest of Latin America RNA Interference (RNAi) Latent
Demand Forecasts in US$ Million by Application: 2018 to 2025
Table 167: RNA Interference (RNAi) Historic Demand Patterns in
Rest of Latin America by Application in US$ Million for
2009-2017
Table 168: RNA Interference (RNAi) Market Share Breakdown in
Rest of Latin America by Application: 2009 VS 2019 VS 2025
Table 169: Rest of Latin America RNA Interference (RNAi) Market
Estimates and Projections in US$ Million by Therapeutics: 2018
to 2025
Table 170: RNA Interference (RNAi) Market in Rest of Latin
America by Therapeutics: A Historic Review in US$ Million for
2009-2017
Table 171: Rest of Latin America RNA Interference (RNAi) Market
Share Breakdown by Therapeutics: 2009 VS 2019 VS 2025
MIDDLE EAST
Table 172: The Middle East RNA Interference (RNAi) Market
Estimates and Forecasts in US$ Million by Region/Country:
2018-2025
Table 173: RNA Interference (RNAi) Market in the Middle East by
Region/Country in US$ Million: 2009-2017
Table 174: The Middle East RNA Interference (RNAi) Market Share
Breakdown by Region/Country: 2009, 2019, and 2025
Table 175: The Middle East RNA Interference (RNAi) Market
Quantitative Demand Analysis in US$ Million by Application:
2018 to 2025
Table 176: RNA Interference (RNAi) Market in the Middle East:
Summarization of Historic Demand Patterns in US$ Million by
Application for 2009-2017
Table 177: The Middle East RNA Interference (RNAi) Market Share
Analysis by Application: 2009 VS 2019 VS 2025
Table 178: The Middle East RNA Interference (RNAi) Market
Estimates and Forecasts in US$ Million by Therapeutics: 2018 to
2025
Table 179: The Middle East RNA Interference (RNAi) Historic
Market by Therapeutics in US$ Million: 2009-2017
Table 180: RNA Interference (RNAi) Market in the Middle East:
Percentage Share Breakdown of Sales by Therapeutics for 2009,
2019, and 2025
IRAN
Table 181: Iranian Demand Estimates and Forecasts for RNA
Interference (RNAi) in US$ Million by Application: 2018 to 2025
Table 182: Iranian RNA Interference (RNAi) Market in US$
Million by Application: 2009-2017
Table 183: RNA Interference (RNAi) Market Share Shift in Iran
by Application: 2009 VS 2019 VS 2025
Table 184: Iranian Market for RNA Interference (RNAi): Annual
Sales Estimates and Projections in US$ Million by Therapeutics
for the Period 2018-2025
Table 185: RNA Interference (RNAi) Market in Iran: Historic
Sales Analysis in US$ Million by Therapeutics for the Period
2009-2017
Table 186: Iranian RNA Interference (RNAi) Market Share
Analysis by Therapeutics: 2009 VS 2019 VS 2025
ISRAEL
Table 187: Israeli RNA Interference (RNAi) Addressable Market
Opportunity in US$ Million by Application: 2018-2025
Table 188: RNA Interference (RNAi) Market in Israel:
Summarization of Historic Demand in US$ Million by Application
for the Period 2009-2017
Table 189: Israeli RNA Interference (RNAi) Market Share
Analysis by Application: 2009 VS 2019 VS 2025
Table 190: Israeli RNA Interference (RNAi) Market Estimates and
Forecasts in US$ Million by Therapeutics: 2018-2025
Table 191: RNA Interference (RNAi) Market in Israel in US$
Million by Therapeutics: A Historic Review for the Period
2009-2017
Table 192: Israeli RNA Interference (RNAi) Market Share
Breakdown by Therapeutics: 2009 VS 2019 VS 2025
SAUDI ARABIA
Table 193: Saudi Arabian Demand for RNA Interference (RNAi) in
US$ Million by Application: 2018 to 2025
Table 194: RNA Interference (RNAi) Market Review in Saudi
Arabia in US$ Million by Application: 2009-2017
Table 195: Saudi Arabian RNA Interference (RNAi) Market Share
Breakdown by Application: 2009 VS 2019 VS 2025
Table 196: Saudi Arabian RNA Interference (RNAi) Market Growth
Prospects in US$ Million by Therapeutics for the Period
2018-2025
Table 197: RNA Interference (RNAi) Historic Market Analysis in
Saudi Arabia in US$ Million by Therapeutics: 2009-2017
Table 198: Saudi Arabian RNA Interference (RNAi) Market by
Therapeutics: Percentage Breakdown of Sales for 2009, 2019, and
2025
UNITED ARAB EMIRATES
Table 199: RNA Interference (RNAi) Market in the United Arab
Emirates: Recent Past, Current and Future Analysis in US$
Million by Application for the Period 2018-2025
Table 200: United Arab Emirates RNA Interference (RNAi)
Historic Market Analysis in US$ Million by Application:
2009-2017
Table 201: RNA Interference (RNAi) Market Share Distribution in
United Arab Emirates by Application: 2009 VS 2019 VS 2025
Table 202: RNA Interference (RNAi) Market in the United Arab
Emirates: Recent Past, Current and Future Analysis in US$
Million by Therapeutics for the Period 2018-2025
Table 203: United Arab Emirates RNA Interference (RNAi)
Historic Market Analysis in US$ Million by Therapeutics:
2009-2017
Table 204: RNA Interference (RNAi) Market Share Distribution in
United Arab Emirates by Therapeutics: 2009 VS 2019 VS 2025
REST OF MIDDLE EAST
Table 205: RNA Interference (RNAi) Market in Rest of Middle
East: Annual Sales Estimates and Forecasts in US$ Million by
Application for the Period 2018-2025
Table 206: Rest of Middle East RNA Interference (RNAi) Market
in Retrospect in US$ Million by Application: 2009-2017
Table 207: RNA Interference (RNAi) Market Share Distribution in
Rest of Middle East by Application: 2009 VS 2019 VS 2025
Table 208: RNA Interference (RNAi) Market in Rest of Middle
East: Recent Past, Current and Future Analysis in US$ Million
by Therapeutics for the Period 2018-2025
Table 209: Rest of Middle East RNA Interference (RNAi) Historic
Market Analysis in US$ Million by Therapeutics: 2009-2017
Table 210: Rest of Middle East RNA Interference (RNAi) Market
Share Breakdown by Therapeutics: 2009 VS 2019 VS 2025
AFRICA
Table 211: African RNA Interference (RNAi) Latent Demand
Forecasts in US$ Million by Application: 2018 to 2025
Table 212: RNA Interference (RNAi) Historic Demand Patterns in
Africa by Application in US$ Million for 2009-2017
Table 213: RNA Interference (RNAi) Market Share Breakdown in
Africa by Application: 2009 VS 2019 VS 2025
Table 214: African RNA Interference (RNAi) Market Estimates and
Projections in US$ Million by Therapeutics: 2018 to 2025
Table 215: RNA Interference (RNAi) Market in Africa by
Therapeutics: A Historic Review in US$ Million for 2009-2017
Table 216: African RNA Interference (RNAi) Market Share
Breakdown by Therapeutics: 2009 VS 2019 VS 2025
IV. COMPETITION
ALNYLAM PHARMACEUTICALS, INC.
BENITEC BIOPHARMA
IONIS PHARMACEUTICALS, INC.
QIAGEN
QUARK PHARMACEUTICALS
SILENCE THERAPEUTICS PLC
V. CURATED RESEARCH
Read the full report: https://www.reportlinker.com/p05818086/?utm_source=PRN
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001
SOURCE Reportlinker
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article